Cargando…

Success Predictors of Adjuvant Chemotherapy in Node-Negative Breast Cancer Patients Under 55 years(1)

Background: Adjuvant systemic chemotherapy (ASCT) in lymph node-negative breast (LN−) cancers improves survival. The majority of (LN−) patients receive ASCT when the St. Gallen criteria or its modifications are used, as accurate identifiers which patients benefit from ASCT are lacking. This may impl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janssen, Emiel A. M., van Diest, Paul J., Søiland, Håvard, Gudlaugson, Einar, Nysted, Arne, Voorhorst, Feja J., Vermorken, Jan B., Søreide, Jon-Arne, Baak, Jan P. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2006
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617792/ https://www.ncbi.nlm.nih.gov/pubmed/17167182 http://dx.doi.org/10.1155/2006/152341

Ejemplares similares

Comparing the Prognostic Value of PTEN and Akt Expression with the Mitotic Activity Index in Adjuvant Chemotherapy-Treated Node-Negative Breast Cancer patients aged <55 years
por: Janssen, Emiel A. M., et al.
Publicado: (2007)

LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
por: Janssen, Emiel A. M., et al.
Publicado: (2009)

Emerging Concepts of Apolipoprotein D with Possible Implications for Breast Cancer
por: Søiland, Håvard, et al.
Publicado: (2007)

Consistent Condom Use Increases the Regression Rate of Cervical Intraepithelial Neoplasia 2–3
por: Munk, Ane Cecilie, et al.
Publicado: (2012)

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial
por: Lende, Tone Hoel, et al.
Publicado: (2019)

Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer
por: Jonsdottir, Kristin, et al.
Publicado: (2014)

Cell-cycle and Apoptosis Regulators (p16(INK4A), p21(CIP1), α-Catenin, Survivin, and hTERT) and Morphometry-Defined MPECs Predict Metachronous Cancer Development in Colorectal Adenoma Patients
por: Soreide, Kjetil, et al.
Publicado: (2007)

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers
por: Jonsdottir, Kristin, et al.
Publicado: (2012)

The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer
por: Skaland, Ivar, et al.
Publicado: (2009)

Adult pancreatic hemangioma in pregnancy – concerns and considerations of a rare case
por: Søreide, Jon Arne, et al.
Publicado: (2015)

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients — an explorative study
por: Lende, Tone Hoel, et al.
Publicado: (2019)

Hepatoid adenocarcinoma of the stomach – proper identification and treatment remain a challenge
por: Søreide, Jon Arne, et al.
Publicado: (2016)

Therapeutic Approaches to Gastric Hepatoid Adenocarcinoma: Current Perspectives
por: Søreide, Jon Arne
Publicado: (2019)

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients
por: Egeland, Nina Gran, et al.
Publicado: (2019)

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
por: Helland, Thomas, et al.
Publicado: (2017)

Scoring systems for outcome prediction in patients with perforated peptic ulcer
por: Thorsen, Kenneth, et al.
Publicado: (2013)

What Is the Best Predictor of Mortality in Perforated Peptic Ulcer Disease? A Population-Based, Multivariable Regression Analysis Including Three Clinical Scoring Systems
por: Thorsen, Kenneth, et al.
Publicado: (2014)

Esophageal perforation: diagnostic work-up and clinical decision-making in the first 24 hours
por: Søreide, Jon Arne, et al.
Publicado: (2011)

The overriding role of surgery and tumor grade for long‐term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population‐based cohort study
por: Søreide, Jon Arne, et al.
Publicado: (2021)

Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
por: Helland, Thomas, et al.
Publicado: (2020)

Is adjuvant chemotherapy better than neoadjuvant chemotherapy for those with node positive disease?
por: Zabell, Joseph, et al.
Publicado: (2018)

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients
por: Egeland, Nina G., et al.
Publicado: (2015)

Adjuvant Chemotherapy in Node-Negative Advanced Gastric Cancer Patients
por: Su, Jian-wei, et al.
Publicado: (2022)

Reproducibility and Prognostic Value of WHO1973 and WHO2004 Grading Systems in TaT1 Urothelial Carcinoma of the Urinary Bladder
por: Mangrud, Ok Målfrid, et al.
Publicado: (2014)

Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas
por: Kvikstad, Vebjørn, et al.
Publicado: (2019)

The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer
por: Oltedal, Satu, et al.
Publicado: (2018)

Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model
por: Baak, Jan P. A., et al.
Publicado: (2005)

Predictive Testing of Early CIN Behaviour by Molecular Biomarkers
por: Baak, Jan P. A., et al.
Publicado: (2005)

Trends in Diagnosis and Surgical Management of Patients with Perforated Peptic Ulcer
por: Thorsen, Kenneth, et al.
Publicado: (2011)

Primary Leiomyosarcoma of the Pancreas—a Case Report and a Comprehensive Review
por: Søreide, Jon Arne, et al.
Publicado: (2016)

High Frequency Microsatellite Instability Has a Prognostic Value in Endometrial Endometrioid Adenocarcinoma, But Only in FIGO Stage 1 Cases
por: Steinbakk, Anita, et al.
Publicado: (2010)

The Relationship between Syntactic Structure Analysis Features, Histological Grade and High-Risk HPV DNA in Cervical Intraepithelial Neoplasia
por: Kruse, Arnold‐Jan, et al.
Publicado: (2004)

The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer
por: Klintman, Marie, et al.
Publicado: (2013)

Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review
por: Eliassen, Finn Magnus, et al.
Publicado: (2023)

Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients
por: Oki, Eiji, et al.
Publicado: (2021)

The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
por: Jeong, Hyehyun, et al.
Publicado: (2022)

Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer
por: Tominaga, Tetsuro, et al.
Publicado: (2016)

Adjuvant chemotherapy in pathological node-negative non-small cell lung cancer
por: Cheng, Ya-Fu, et al.
Publicado: (2023)

Molecular Subtypes in Stage II-III Colon Cancer Defined by Genomic Instability: Early Recurrence-Risk Associated with a High Copy-Number Variation and Loss of RUNX3 and CDKN2A
por: Berg, Marianne, et al.
Publicado: (2015)

Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis
por: Søreide, Kjetil, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0q8oihoc9tgvjn9b88d310ppjh